Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing

被引:26
作者
Abaji, Rachid [1 ,2 ]
Ceppi, Francesco [3 ,4 ]
Patel, Swati [1 ]
Gagne, Vincent [1 ]
Xu, Chang J. [1 ]
Spinella, Jean-Francois [1 ]
Colombini, Antonella [5 ]
Parasole, Rosanna [6 ]
Buldini, Barbara [7 ]
Basso, Giuseppe [7 ]
Conter, Valentino [5 ]
Cazzaniga, Giovanni [8 ]
Leclerc, Jean-Marie [1 ,9 ]
Laverdiere, Caroline [1 ,9 ]
Sinnett, Daniel [1 ,9 ]
Krajinovic, Maja [1 ,2 ,8 ]
机构
[1] CHU St Justine Res Ctr, Charles Bruneau Canc Ctr, Montreal, PQ H3T 1C5, Canada
[2] Univ Montreal, Dept Pharmacol & Physiol, Fac Med, Montreal, PQ H3C 3J7, Canada
[3] Univ Hosp Lausanne, Dept Woman Mother Child, Div Pediat, Pediat Hematol Oncol Unit, CH-1004 Lausanne, Switzerland
[4] Univ Hosp Lausanne, Dept Woman Mother Child, Div Pediat, Pediat Hematol Oncol Res Lab, CH-1004 Lausanne, Switzerland
[5] Univ Milano Bicocca, Dept Pediat, Osped S Gerardo, I-20835 Monza, Italy
[6] Santobono Pausilipon Hosp, Dept Pediat Hematooncol, I-80129 Naples, Italy
[7] Univ Padua, Dept Woman & Child Hlth, Lab Haematol Oncol, I-35128 Padua, Italy
[8] Univ Milano Bicocca, Dept Pediat, Ctr Ric Tettamanti, I-20835 Monza, Italy
[9] Univ Montreal, Dept Pediat, Fac Med, Montreal, PQ H4A 3J1, Canada
基金
加拿大健康研究院;
关键词
acute lymphoblastic leukemia; adverse drug reactions; association study; cancer; genetics; pharmacogenetics; polymorphism; vincristine-induced peripheral neuropathy; whole-exome sequencing; INDUCED PERIPHERAL NEUROPATHY; MARIE-TOOTH DISEASE; MUSCULAR-DYSTROPHY; VINCRISTINE PHARMACOKINETICS; AXONAL NEUROPATHY; CHILDREN; NEUROTOXICITY; POLYMORPHISMS; ASSOCIATION; TOXICITY;
D O I
10.2217/pgs-2018-0093
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: To identify genetic markers associated with vincristine-induced peripheral neuropathy (VIPN) in childhood acute lymphoblastic leukemia. Patients & methods: Whole-exome sequencing data were combined with exome-wide association study to identify predicted-functional germline variants associated with high-grade VIPN. Genotyping was then performed for top-ranked signals (n =237), followed by validation in independent replication group (n =405). Results: Minor alleles of rs2781377/SYNE2 (p=0.01) and rs10513762/MRPL47 (p=0.01) showed increased risk, whereas that of rs3803357/BAHD1 had a protective effect (p=0.007). Using a genetic model based on weighted genetic risk scores, an additive effect of combining these loci was observed (p=0.003). The addition of rs1135989/ACTG1 further enhanced model performance (p=0.0001). Conclusion: Variants in SYNE2, MRPL47 and BAHD1 genes are putative new risk factors for VIPN in childhood acute lymphoblastic leukemia.
引用
收藏
页码:1181 / 1193
页数:13
相关论文
共 55 条
[1]   Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients [J].
Abaji, Rachid ;
Gagne, Vincent ;
Xu, Chang Jiang ;
Spinella, Jean-Francois ;
Ceppi, Francesco ;
Laverdiere, Caroline ;
Leclerc, Jean-Marie ;
Sallan, Stephen E. ;
Neuberg, Donna ;
Kutok, Jeffery L. ;
Silverman, Lewis B. ;
Sinnett, Daniel ;
Krajinovic, Maja .
ONCOTARGET, 2017, 8 (27) :43752-43767
[2]  
Albers J, 2007, COCHRANE DB SYST REV, V3
[3]   CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia [J].
Aplenc, R ;
Glatfelter, W ;
Han, P ;
Rappaport, E ;
La, M ;
Cnaan, A ;
Blackwood, MA ;
Lange, B ;
Rebbeck, T .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (02) :240-244
[4]   Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy [J].
Benedetti, S ;
Bertini, E ;
Iannaccone, S ;
Angelini, C ;
Trisciani, M ;
Toniolo, D ;
Sferrazza, B ;
Carrera, P ;
Comi, G ;
Ferrari, M ;
Quattrini, A ;
Previtali, SC .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (07) :1019-1021
[5]   Human BAHD1 promotes heterochromatic gene silencing [J].
Bierne, Helene ;
Tham, To Nam ;
Batsche, Eric ;
Dumay, Anne ;
Leguillou, Morwenna ;
Kerneis-Golsteyn, Sophie ;
Regnault, Beatrice ;
Seeler, Jacob S. ;
Muchardt, Christian ;
Feunteun, Jean ;
Cossart, Pascale .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (33) :13826-13831
[6]   Nesprins in health and disease [J].
Cartwright, Sarah ;
Karakesisoglou, Iakowos .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2014, 29 :169-179
[7]  
Ceppi F, 2014, PHARMACOGENOMICS, V15, P1105, DOI [10.2217/PGS.14.68, 10.2217/pgs.14.68]
[8]   Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study [J].
Conter, Valentino ;
Bartram, Claus R. ;
Valsecchi, Maria Grazia ;
Schrauder, Andre ;
Panzer-Gruemayer, Renate ;
Moericke, Anja ;
Arico, Maurizio ;
Zimmermann, Martin ;
Mann, Georg ;
De Rossi, Giulio ;
Stanulla, Martin ;
Locatelli, Franco ;
Basso, Giuseppe ;
Niggli, Felix ;
Barisone, Elena ;
Henze, Guenter ;
Ludwig, Wolf-Dieter ;
Haas, Oskar A. ;
Cazzaniga, Giovanni ;
Koehler, Rolf ;
Silvestri, Daniela ;
Bradtke, Jutta ;
Parasole, Rosanna ;
Beier, Rita ;
van Dongen, Jacques J. M. ;
Biondi, Andrea ;
Schrappe, Martin .
BLOOD, 2010, 115 (16) :3206-3214
[9]   PHARMACOKINETICS OF VINCRISTINE IN CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA [J].
CROM, WR ;
DEGRAAF, SSN ;
SYNOLD, T ;
UGES, DRA ;
BLOEMHOF, H ;
RIVERA, G ;
CHRISTENSEN, ML ;
MAHMOUD, H ;
EVANS, WE .
JOURNAL OF PEDIATRICS, 1994, 125 (04) :642-649
[10]   Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score [J].
De Jager, Philip L. ;
Chibnik, Lori B. ;
Cui, Jing ;
Reischl, Joachim ;
Lehr, Stephan ;
Simon, K. Claire ;
Aubin, Cristin ;
Bauer, David ;
Heubach, Juergen F. ;
Sandbrink, Rupert ;
Tyblova, Michaela ;
Lelkova, Petra ;
Havrdova, Eva ;
Pohl, Christoph ;
Horakova, Dana ;
Ascherio, Alberto ;
Hafler, David A. ;
Karlson, Elizabeth W. .
LANCET NEUROLOGY, 2009, 8 (12) :1111-1119